Neurological complications of anti-PD-1 antibodies: shall we be more concerned?
ZATT, TDP2, and SUMO2: breaking the tie that binds TOP2 to DNA
Evolutionary acquired robustness and vulnerability in cancer genome: negligible negative selection in carcinogenesis
Fibroblast growth factor signaling as a bypass mechanism of the androgen receptor pathway: new perspectives for castrationresistant prostate cancer
Myc and Ras, the Bonnie and Clyde of immune evasion
Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic
The emerging landscape of lncRNAs in diabetic nephropathy
A human mutated gene is guillotining spermatozoa
Hypofractionated whole breast irradiation is cost-effective—but is that enough to change practice?
Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas—a new standard
Editorial: fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Duloxetine for AI-associated joint pain in breast cancer patients
Temozolomide—the jack of all gliomas? Reviewing the interim results of the CATNON trial for 1p/19q non-co-deleted anaplastic glioma
When the inhibitor is turned into stimulator: novel aspects in T cell engineering
There must be another way—disulfiram and cancer treatment: editorial on “Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4”
Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4
How many pancreatic cysts are out there and how to best manage them?
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma
Abundant options to avoid toxicity and alternative strategies for human epidermal growth factor receptor 2-positive and hormone receptor-positive advanced breast cancer
Role of enhancer activation in pancreatic cancer metastasis
Circular RNA FBXW7: implication in glioma tumorigenesis
Letter to the Editor
This supplement was published without any sponsorship or funding.